Labiotech.eu

liver transplant cambridge university research

More News! 6 Jul 2017

Lab-Grown Bile Ducts Can Replace Liver Transplant in Mice

A new study describes a method that could be used to regenerate bile ducts in children with biliary atresia instead of waiting for a liver transplant. Researchers at the University of Cambridge might have found an alternative to transplant for children with liver disease. Their results, published today in Nature Medicine, reveal that primitive bile ducts grown […]

July 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Jul 2017

Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II

Prothena and Roche are advancing their Parkinson’s antibody to Phase II, triggering a new milestone payment from what is proving a lucrative deal for Prothena. Prothena, the largest biopharma in Ireland, and its partner Roche have announced the first patient has been enrolled in a Phase II trial testing an antibody treatment for Parkinson’s. Reaching […]

July 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

universal cancer vaccine mrna biontech personalized medicine

News and Trends 5 Jul 2017

Results are in from the First Human Trial of an Universal Cancer Vaccine

BioNTech has published results from the first clinical trial for an mRNA-based individualized vaccine with the potential to target all cancer types. Published in Nature, the results from the first trial in humans with a personalized mRNA cancer vaccine hint that BioNTech is on a promising track towards the development of a universal cancer vaccine. All […]

July 5, 2017 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 5 Jul 2017

Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year

With the addition of uveitis, Galapagos and Gilead are raising to 10 the number of indications in filgotinib’s clinical pipeline. Galapagos and Gilead clearly have big expectations for filgotinib. The small molecule is already in Phase III for rheumatoid arthritis, Crohn’s disease and ulcerative colitis. The team is now launching a new Phase II trial in […]

July 5, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 5 Jul 2017

Cutting Through the BS in Biopharma: How To Spot Hype

Faced with the oft-quoted figure that 90% of clinical trials end in failure, how can patients, investors, and readers be spared more disappointment? After discussing failures in biotech at Refresh earlier in June, I headed to Copenhagen last week for the European Conference for Science Journalists to cajole a panel into discussing how some of these stories feature […]

July 5, 2017 - 4 minutesmins - By Evelyn Warner

News and Trends 4 Jul 2017

British Liquid Biopsy for Ovarian Cancer Outperforms the Gold Standard

The British company Angle has announced results from a large-scale trial that seem to indicate its liquid biopsy technology could surpass the gold standard in ovarian cancer diagnosis. Angle, in the UK, is developing liquid biopsy tests to replace biopsies in the diagnosis of cancer. The company has announced results from a 400-patient trial in […]

July 4, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 3 Jul 2017

From Rockets to DNA – From SpaceX to CRISPR

With CRISPR being one of the most significant discoveries in genome engineering history, many scientists are now turning towards it as a basic foundation of their research. In response, companies are developing new technologies and products designed to help these very scientists become more effective in their research. One such company is Silicon Valley entity […]

July 3, 2017 - 6 minutesmins - By External Contributor

Interview 3 Jul 2017

Video: Is mRNA a True Game-Changer? Fireside Chat with Sean Marett, COO of BioNTech

Sean Marett took a red-eye from New York to speak at Refresh last month: here are his thoughts on how mRNA therapeutics are taking biotech by storm! mRNA has become one of the next big things in biotech, and Germany-based BioNTech is at the forefront of the wave, developing personalized treatments for cancer. “We try to provide individualized […]

July 3, 2017 - 1 minutemin - By Evelyn Warner

News and Trends 3 Jul 2017

Scottish AI Biotech Recruits Another Pharma Partner in €37M Deal

After Sanofi recruited Exscientia in a €250M deal last May, GSK has taken an interest in the startup and invested in a collaboration of its own. Artificial intelligence has been carving out a niche for itself in biotech, and Exscientia is fast establishing itself as a key player in the field. In May, the company signed a […]

July 3, 2017 - 1 minutemin - By Evelyn Warner

Interview 3 Jul 2017

These Norwegian Biotech Execs are Bringing Back Cancer Vaccines & Oncolytic Viruses

We talked to CEO Øystein Soug and CMO Magnus Jäderberg of Targovax about why the company’s technologies may succeed where others have failed. In 2010, Targovax rose from the ashes of Norsk Hydro Pharma, the discontinued therapeutic development arm of the conglomerate. The Oslo-based biotech is taking a stand against tough-to-treat cancers like that of […]

July 3, 2017 - 8 minutesmins - By Evelyn Warner

News and Trends 1 Jul 2017

Quantum Worms from London win the Biodesign Challenge 2017

A team of students from Central Saint Martins, London, has won this year’s biodesign challenge with a project in which worms turn into tech factories. Every year, teams working at the intersection of biology and design compete to win the Biodesign Challenge held at the famous New York City’s Museum of Modern Art (MoMA). This year’s edition […]

July 1, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 30 Jun 2017

Belgian Biotech Starts Phase Ib with an off-the-shelf mRNA Therapy for Melanoma

eTheRNA has started a Phase Ib trial in patients with melanoma to test a cancer immunotherapy based on off-the-shelf mRNA technology. eTheRNA is one of the few companies working in mRNA therapies that are running clinical trials. The Belgian biotech has announced the start of a Phase Ib trial with its candidate TriMix-MEL, also called ECI-006, in patients […]

June 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Lab-Grown Bile Ducts Can Replace Liver Transplant in Mice

Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II

Results are in from the First Human Trial of an Universal Cancer Vaccine

Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year

Cutting Through the BS in Biopharma: How To Spot Hype

British Liquid Biopsy for Ovarian Cancer Outperforms the Gold Standard

From Rockets to DNA – From SpaceX to CRISPR

Video: Is mRNA a True Game-Changer? Fireside Chat with Sean Marett, COO of BioNTech

Scottish AI Biotech Recruits Another Pharma Partner in €37M Deal

These Norwegian Biotech Execs are Bringing Back Cancer Vaccines & Oncolytic Viruses

Quantum Worms from London win the Biodesign Challenge 2017

Belgian Biotech Starts Phase Ib with an off-the-shelf mRNA Therapy for Melanoma

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!